Want to see DE:RHK full AI Analyst Report?
RHON-KLINIKUM AG (RHK) Ratios
RHON-KLINIKUM AG Ratios
DE:RHK's free cash flow for Q2 2026 was $0.00. For the 2026 fiscal year, DE:RHK's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.60 | 2.23 | 2.35 | 2.37 | 2.24 |
| Quick Ratio | 2.49 | 2.14 | 2.25 | 2.25 | 2.11 |
| Cash Ratio | 0.50 | 0.69 | 0.61 | 0.27 | 0.46 |
| Solvency Ratio | 0.21 | 0.20 | 0.21 | 0.21 | 0.22 |
| Operating Cash Flow Ratio | 0.19 | 0.32 | 0.32 | 0.21 | 0.36 |
| Short-Term Operating Cash Flow Coverage | 15.77 | 4.00 | 113.42 | 7.57 | 97.79 |
| Net Current Asset Value | $ 422.95M | $ 373.60M | $ 298.91M | $ 235.10M | $ 170.26M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.07 | 0.08 | 0.08 | 0.09 | 0.10 |
| Debt-to-Equity Ratio | 0.09 | 0.12 | 0.12 | 0.13 | 0.13 |
| Debt-to-Capital Ratio | 0.08 | 0.10 | 0.11 | 0.11 | 0.12 |
| Long-Term Debt-to-Capital Ratio | 0.08 | 0.08 | 0.10 | 0.10 | 0.11 |
| Financial Leverage Ratio | 1.38 | 1.43 | 1.41 | 1.39 | 1.39 |
| Debt Service Coverage Ratio | 8.55 | 3.15 | 23.39 | 8.24 | 24.56 |
| Interest Coverage Ratio | 1.46 | 14.16 | 10.92 | 8.81 | 9.54 |
| Debt to Market Cap | 0.14 | 0.15 | 0.21 | 0.15 | 0.16 |
| Interest Debt Per Share | 1.87 | 2.29 | 2.29 | 2.42 | 2.43 |
| Net Debt to EBITDA | -0.69 | -1.07 | -0.48 | 0.76 | 0.33 |
| Profitability Margins | |||||
| Gross Profit Margin | 8.67% | 10.77% | 11.69% | 69.12% | 13.03% |
| EBIT Margin | 0.23% | 3.74% | 2.96% | 2.60% | 2.18% |
| EBITDA Margin | 3.59% | 7.66% | 6.72% | 7.34% | 7.15% |
| Operating Profit Margin | 0.23% | 3.02% | 2.33% | 2.50% | 2.18% |
| Pretax Profit Margin | 2.32% | 3.52% | 2.75% | 2.33% | 1.95% |
| Net Profit Margin | 1.78% | 2.72% | 2.23% | 1.74% | 2.02% |
| Continuous Operations Profit Margin | 1.87% | 2.83% | 2.32% | 1.86% | 2.16% |
| Net Income Per EBT | 76.69% | 77.13% | 81.11% | 74.77% | 103.41% |
| EBT Per EBIT | 1022.99% | 116.73% | 118.14% | 93.12% | 89.65% |
| Return on Assets (ROA) | 1.89% | 2.34% | 2.19% | 1.47% | 1.70% |
| Return on Equity (ROE) | 2.61% | 3.35% | 3.09% | 2.05% | 2.36% |
| Return on Capital Employed (ROCE) | 0.30% | 3.32% | 2.82% | 2.55% | 2.19% |
| Return on Invested Capital (ROIC) | 0.24% | 2.61% | 2.36% | 2.03% | 2.19% |
| Return on Tangible Assets | 2.09% | 2.58% | 2.43% | 1.65% | 1.91% |
| Earnings Yield | 4.05% | 4.66% | 5.78% | 2.46% | 2.94% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.82 | 3.84 | 4.40 | 4.11 | 5.02 |
| Payables Turnover | 23.46 | 22.42 | 22.92 | 6.38 | 5.94 |
| Inventory Turnover | 43.57 | 38.01 | 44.77 | 13.40 | 12.99 |
| Fixed Asset Turnover | 2.58 | 2.09 | 2.19 | 1.76 | 1.64 |
| Asset Turnover | 1.06 | 0.86 | 0.98 | 0.85 | 0.84 |
| Working Capital Turnover Ratio | 3.69 | 3.35 | 4.08 | 3.93 | 4.45 |
| Cash Conversion Cycle | 88.27 | 88.28 | 75.27 | 58.81 | 39.27 |
| Days of Sales Outstanding | 95.46 | 94.95 | 83.04 | 88.78 | 72.65 |
| Days of Inventory Outstanding | 8.38 | 9.60 | 8.15 | 27.23 | 28.09 |
| Days of Payables Outstanding | 15.56 | 16.28 | 15.93 | 57.20 | 61.48 |
| Operating Cycle | 103.83 | 104.56 | 91.20 | 116.01 | 100.74 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.96 | 1.91 | 1.63 | 0.90 | 1.46 |
| Free Cash Flow Per Share | -0.52 | 0.85 | 0.69 | -0.25 | 0.29 |
| Dividend Paid and CapEx Coverage Ratio | 0.61 | 1.81 | 1.50 | 1.04 | 1.25 |
| Capital Expenditure Coverage Ratio | 0.65 | 1.81 | 1.74 | 1.04 | 1.25 |
| Operating Cash Flow Coverage Ratio | 0.53 | 0.85 | 0.73 | 0.38 | 0.61 |
| Operating Cash Flow to Sales Ratio | 0.03 | 0.08 | 0.06 | 0.04 | 0.07 |
| Free Cash Flow Yield | -4.07% | 6.15% | 6.90% | -1.65% | 2.05% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 24.42 | 21.38 | 17.29 | 40.73 | 34.02 |
| Price-to-Sales (P/S) Ratio | 0.44 | 0.58 | 0.39 | 0.71 | 0.69 |
| Price-to-Book (P/B) Ratio | 0.64 | 0.72 | 0.53 | 0.84 | 0.80 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -24.57 | 16.27 | 14.49 | -60.60 | 48.86 |
| Price-to-Operating Cash Flow Ratio | 13.18 | 7.29 | 6.14 | 16.98 | 9.87 |
| Price-to-Earnings Growth (PEG) Ratio | -1.22 | 1.77 | 0.33 | -4.28 | 0.02 |
| Enterprise Value Multiple | 11.56 | 6.55 | 5.26 | 10.41 | 9.94 |
| Enterprise Value | 802.03M | 800.17M | 613.17M | 1.11B | 996.02M |
| EV to EBITDA | 11.56 | 6.55 | 5.26 | 10.41 | 9.94 |
| EV to Sales | 0.41 | 0.50 | 0.35 | 0.76 | 0.71 |
| EV to Free Cash Flow | -23.18 | 13.99 | 13.27 | -65.39 | 50.56 |
| EV to Operating Cash Flow | 12.43 | 6.27 | 5.63 | 18.33 | 10.22 |
| Tangible Book Value Per Share | 17.68 | 17.21 | 16.50 | 16.02 | 15.58 |
| Shareholders’ Equity Per Share | 19.73 | 19.36 | 18.70 | 18.28 | 17.90 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.19 | 0.20 | 0.16 | 0.20 | -0.10 |
| Revenue Per Share | 28.92 | 23.84 | 25.92 | 21.60 | 20.94 |
| Net Income Per Share | 0.51 | 0.65 | 0.58 | 0.38 | 0.42 |
| Tax Burden | 0.77 | 0.77 | 0.81 | 0.75 | 1.03 |
| Interest Burden | 10.23 | 0.94 | 0.93 | 0.89 | 0.90 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.03 | 0.04 | 0.04 | 0.02 | 0.01 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.87 | 2.82 | 2.82 | 2.40 | 3.56 |
Currency in EUR